Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 1/20 | 0.36 |
| ▸ | NR3C2 | P08235 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | MASTL | Q96GX5 | 1/20 | 0.32 |
| ▸ | P2RX7 | Q99572 | 6/20 | 0.32 |
| ▸ | ANO1 | Q5XXA6 | 1/20 | 0.32 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.32 |
| ▸ | PIK3C3 | Q8NEB9 | 1/20 | 0.31 |
| ▸ | GSK3B | P49841 | 2/20 | 0.31 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | TBK1 | Q9UHD2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30953425 | 0.92 | NR3C2 (0.34) | NR3C2MASTLP2RX7ANO1LNPEP | |
| SCHEMBL30953477 | 0.92 | NR3C2 (0.34) | NR3C2MASTLP2RX7ANO1LNPEP | |
| SCHEMBL30953482 | 0.82 | ACACB (0.36) | ACACBNR3C2MAPK1ANO1LNPEP | |
| SCHEMBL30953277 | 0.82 | ACACB (0.36) | ACACBNR3C2MAPK1ANO1LNPEP | |
| SCHEMBL30953089 | 0.81 | IL17A (0.36) | ACACBNR3C2TBK1 | |
| SCHEMBL30953361 | 0.81 | RAB9A (0.35) | NR3C2LNPEPGSK3BTRPV1MAPT | |
| SCHEMBL30953451 | 0.80 | NR3C2 (0.32) | NR3C2P2RX7ANO1LNPEPPIK3C3 | |
| SCHEMBL30953331 | 0.80 | MEN1 (0.33) | NR3C2MAPK1ANO1LNPEPPIK3C3 | |
| SCHEMBL30953251 | 0.78 | MAPK1 (0.36) | MAPK1 | |
| SCHEMBL30953245 | 0.77 | NR3C2 (0.36) | NR3C2GSK3BTRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4630115-A1 | THERAPEUTIC COMPOUNDS | Sanofi (FR) | 2025-10-15 | — | — | EP | disclosed |
| WO-2024121427-A1 | THERAPEUTIC COMPOUNDS | SANOFI (FR) | 2024-06-13 | — | — | WO | disclosed |